Wolverine Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Wolverine Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-13,996	Closed	-$2.11M	–	2269
2021 Q1	$2.11M	Buy	+13,996	New	+$2.22M	0.02%	414
2019 Q3	–	Sell	-10,800	Closed	-$1.13M	–	1481
2019 Q2	$1.18M	Buy	+10,800	New	+$1.15M	0.02%	588
2013 Q3	–	Sell	-498	Closed	-$28K	–	2771
2013 Q2	$28K	Buy	+498	New	+$28.8K	﹤0.01%	1901

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wolverine Asset Management's IBB Position: Q2 2021 in Review

Wolverine Asset Management sold out of iShares Biotechnology ETF (IBB) in Q2 2021, closing a stake of 13,996 shares — an estimated $2.11M sold.

Wolverine Asset Management first reported a position in IBB in Q2 2013 and held it in 3 quarters. The position peaked at $2.11M in Q1 2021. 864 funds tracked by Wall St. Rank hold IBB as of Q2 2021.

Wolverine Asset Management reported no remaining iShares Biotechnology ETF position as of Q2 2021 after selling out during the quarter.
Wolverine Asset Management sold 13,996 iShares Biotechnology ETF shares in Q2 2021, an estimated $2.11M.
Wolverine Asset Management first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 3 quarters.
Wolverine Asset Management's iShares Biotechnology ETF position peaked at $2.11M in Q1 2021.
864 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2021.

Based on Wolverine Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.